By combining databases, the m5C prediction website, and the MeRIP-qPCR assay, Zhao et al. revealed for the first time that NSUN4, as a key writer for controlling m5C levels in glioma, mediates changes in m5C levels to promote the stability of CDC42 mRNA. The gene discussed is NSUN4; the disease is glioma.